|
RGNT Regentis Biomaterials Ltd 1912966 |
| Income Statement |
|
Net Income
|
2025-12-31
|
$-13,648,000.00 |
| Balance Sheet |
|
Assets
|
$7,618,000.00 |
|
Current Liabilities
|
$2,874,000.00 |
|
Liabilities
|
$2,874,000.00 |
|
Equity
|
$4,744,000.00 |
|
Shares Out
|
5179378.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,375,000.00 |
| Market Analysis |
Market Cap
|
$10,669,518.68 |
|
Price
|
$2.06 |
|
BVPS
|
0.92 |
|
PB
|
2.24 |
|
EPS
|
-24.16 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:57 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:48 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RGNT documents filed with the SEC.
RGNT Filings
Clear
